Galena AS
Records under this name other than patents Galena AS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Galena AS
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,312,721 | Cyclosporin formulation Formerly held Lapsed on the fee record Ended Nov 6, 2013 · USPTO record | Lapsed on the fee record | Ended Nov 6, 2013 | USPTO record |
| US 6,106,860 | Cyclosporin formulation Formerly held Lapsed on the fee record Ended Aug 22, 2012 · USPTO record | Lapsed on the fee record | Ended Aug 22, 2012 | USPTO record |
| US 6,046,163 | Cyclosporin formulation Formerly held Lapsed on the fee record Ended Apr 4, 2012 · USPTO record | Lapsed on the fee record | Ended Apr 4, 2012 | USPTO record |
| US 6,403,122 | Immunomodulatory pharmaceutical composition adopted to form lyotrophic liquid crystals in contact with an aqueous phase Formerly held Lapsed on the fee record Ended Jun 11, 2006 · USPTO record | Lapsed on the fee record | Ended Jun 11, 2006 | USPTO record |
| US 5,504,208 | Process for the preparation of 3, 14.beta.-dihydroxy-17-normorphinan Term ended Term ended no later than Apr 2, 2016 · Low confidence | Term ended | Term ended no later than Apr 2, 2016 | Low confidence |
| US 5,670,478 | Pharmaceutical containing N-methylated cyclic undecapeptides Term ended Term ended no later than Sep 23, 2017 · Low confidence | Term ended | Term ended no later than Sep 23, 2017 | Low confidence |